Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation

Stimulating the immune system to attack cancer is a promising approach, even for the control of advanced cancers. Several cytokines that promote interferon-γ-dominated immune responses show antitumor activity, with interleukin 12 (IL-12) being of major importance. Here, we used an antibody-IL-12 fus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncoimmunology 2015-07, Vol.4 (7), p.e1014760-e1014760
Hauptverfasser: Schilbach, Karin, Alkhaled, Mohammed, Welker, Christian, Eckert, Franziska, Blank, Gregor, Ziegler, Hendrik, Sterk, Marco, Müller, Friederike, Sonntag, Katja, Wieder, Thomas, Braumüller, Heidi, Schmitt, Julia, Eyrich, Matthias, Schleicher, Sabine, Seitz, Christian, Erbacher, Annika, Pichler, Bernd J, Müller, Hartmut, Tighe, Robert, Lim, Annick, Gillies, Stephen D, Strittmatter, Wolfgang, Röcken, Martin, Handgretinger, Rupert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!